Global Patent Index - EP 1341543 A4

EP 1341543 A4 20090902 - METHODS EMPLOYING AND COMPOSITIONS CONTAINING DEFINED OXIDIZED PHOSPHOLIPIDS FOR PREVENTION AND TREATMENT OF ATHEROSCLEROSIS

Title (en)

METHODS EMPLOYING AND COMPOSITIONS CONTAINING DEFINED OXIDIZED PHOSPHOLIPIDS FOR PREVENTION AND TREATMENT OF ATHEROSCLEROSIS

Title (de)

VERFAHREN UNTER VERWENDUNG VON DEFINIERTEN OXIDIERTEN PHOSPHOLIPIDEN UND DIESE ENTHALTENDE ZUSAMMENSETZUNGEN ZUR PRÄVENTION UND BEHANDLUNG VON ARTERIOSKLEROSE

Title (fr)

PROCEDES FAISANT APPELS A DES PHOSPHOLIPIDES OXYDES DEFINIS, AINSI QUE COMPOSITIONS CONTENANT CES DERNIERS, POUR LA PREVENTION ET LE TRAITEMENT DE L'ATHEROSCLEROSE

Publication

EP 1341543 A4 20090902 (EN)

Application

EP 01997274 A 20011122

Priority

  • IL 0101080 W 20011122
  • US 25257400 P 20001124

Abstract (en)

[origin: WO0241827A2] Novel synthetic forms of etherified oxidized phospholipids and methods of utilizing same for preventing and treating atherosclerosis and other related disorders are provided. In addition, methods of synthesizing esterified oxidized phospholipids and using same for preventing and treating atherosclerosis and other related disorders are also provided.

IPC 1-7

A61K 31/685; A61K 31/215; A61K 31/24; A61K 31/19; A61K 31/20; A61K 31/12; A61K 31/11; A61K 31/075; A61K 31/08; C07F 9/02; C07C 59/235; A61P 9/10

IPC 8 full level

A61K 31/075 (2006.01); A61K 31/08 (2006.01); A61K 31/11 (2006.01); A61K 31/19 (2006.01); A61K 31/20 (2006.01); A61K 31/215 (2006.01); A61K 31/24 (2006.01); A61K 31/6615 (2006.01); A61K 31/685 (2006.01); A61K 45/06 (2006.01); A61P 9/08 (2006.01); A61P 9/10 (2006.01); A61P 41/00 (2006.01); C07C 43/178 (2006.01); C07F 9/10 (2006.01)

CPC (source: EP KR)

A61K 31/075 (2013.01 - EP); A61K 31/08 (2013.01 - EP); A61K 31/11 (2013.01 - EP); A61K 31/19 (2013.01 - EP); A61K 31/20 (2013.01 - EP); A61K 31/215 (2013.01 - EP); A61K 31/24 (2013.01 - EP); A61K 31/685 (2013.01 - EP); A61P 9/00 (2017.12 - EP); A61P 9/08 (2017.12 - EP); A61P 9/10 (2017.12 - EP); A61P 37/06 (2017.12 - EP); A61P 41/00 (2017.12 - EP); A61P 43/00 (2017.12 - EP); C07C 43/1785 (2013.01 - EP); C07C 43/1787 (2013.01 - EP); C07F 9/06 (2013.01 - KR); C07F 9/106 (2013.01 - EP)

Citation (search report)

  • [X] ES 2019552 A6 19910616 - MENARINI LAB [ES]
  • [X] JP S6354386 A 19880308 - TAKEDA CHEMICAL INDUSTRIES LTD
  • [X] JP H01258691 A 19891016 - NIPPON OILS & FATS CO LTD
  • [X] EP 0142333 A2 19850522 - ONO PHARMACEUTICAL CO [JP]
  • [X] WO 8705904 A1 19871008 - UNIV SYDNEY [AU], et al
  • [Y] EP 0121088 A1 19841010 - NATTERMANN A & CIE [DE]
  • [Y] WO 9523592 A1 19950908 - UNIV BRITISH COLUMBIA [CA]
  • [X] KERN H ET AL: "STIMULATION MONOCYTTS AND PLATELETS BY SHORT-CHAIN PHOSPHATIDYLCHOLINES WITH AND WITHOUT TERMINAL CARBOXYL GROUP", BIOCHIMICA ET BIOPHYSICA ACTA. MOLECULAR CELL RESEARCH, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 1394, no. 1, 1 January 1998 (1998-01-01), pages 33 - 42, XP000938800, ISSN: 0167-4889
  • [Y] DEIGNER H P ET AL: "Effect of platelet activating factor on the kinetics of LDL oxidation in vitro", FEBS LETTERS, ELSEVIER, AMSTERDAM, NL, vol. 317, no. 3, 15 February 1993 (1993-02-15), pages 202 - 206, XP025615837, ISSN: 0014-5793, [retrieved on 19930215]
  • [X] LEITINGER N ET AL: "STRUCTURALLY SIMILAR OXIDIZED PHOSPHOLIPIDS DIFFERENTIALLY REGULATE ENDOTHELIAL BINDING OF MONOCYTES AND NEUTROPHILS", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE, WASHINGTON, DC.; US, vol. 96, no. 21, 12 October 1999 (1999-10-12), pages 12010 - 12015, XP002951991, ISSN: 0027-8424
  • [X] SUBBANAGOUNDER G ET AL: "DETERMINANTS OF BIOACTIVITY OF OXIDIZED PHOSPHOLIPIDS SPECIFIC OXIDIZED FATTY ACYL GROUPS AT THE SN-2 POSITION", ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY, LIPPINCOTT WILLIAMS & WILKINS, no. 20, 1 January 2000 (2000-01-01), pages 2248 - 2254, XP002951986, ISSN: 1079-5642
  • [X] ITABE H ET AL: "Preparation of radioactive aldehyde-containing phosphatidylcholine.", ANALYTICAL BIOCHEMISTRY 1 OCT 2000, vol. 285, no. 1, 1 October 2000 (2000-10-01), pages 151 - 155, XP002532603, ISSN: 0003-2697
  • [X] KAMIDO H ET AL: "LIPID ESTER-BOUND ALDEHYDES AMONG COPPER-CATALYZED PEROXIDATION PRODUCTS OF HUMA PLASMA LIPOPROTEINS", JOURNAL OF LIPID RESEARCH, BETHESDA, MD, US, vol. 36, 1 January 1995 (1995-01-01), pages 1876 - 1886, XP002951008, ISSN: 0022-2275
  • [X] ITABE H ET AL: "Oxidized phosphatidylcholines that modify proteins. Analysis by monoclonal antibody against oxidized low density lipoprotein.", THE JOURNAL OF BIOLOGICAL CHEMISTRY 27 DEC 1996, vol. 271, no. 52, 27 December 1996 (1996-12-27), pages 33208 - 33217, XP002532604, ISSN: 0021-9258
  • See references of WO 0241827A2

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

Designated extension state (EPC)

AL LT LV MK RO SI

DOCDB simple family (publication)

WO 0241827 A2 20020530; WO 0241827 A3 20021010; WO 0241827 A9 20030530; AU 1846102 A 20020603; AU 2002218461 B2 20060907; CA 2429817 A1 20020530; CA 2429817 C 20130212; CN 100577174 C 20100106; CN 1529605 A 20040915; EP 1341543 A2 20030910; EP 1341543 A4 20090902; EP 2425841 A1 20120307; IL 156015 A0 20031223; JP 2004537498 A 20041216; JP 2008222726 A 20080925; JP 2012149075 A 20120809; JP 4162486 B2 20081008; JP 5001906 B2 20120815; KR 100865142 B1 20081024; KR 20030077543 A 20031001; MX PA03004517 A 20040326

DOCDB simple family (application)

IL 0101080 W 20011122; AU 1846102 A 20011122; AU 2002218461 A 20011122; CA 2429817 A 20011122; CN 01822215 A 20011122; EP 01997274 A 20011122; EP 11189562 A 20011122; IL 15601501 A 20011122; JP 2002544008 A 20011122; JP 2008151301 A 20080610; JP 2012060309 A 20120316; KR 20037006991 A 20030524; MX PA03004517 A 20011122